Enhydrobacter aerosaccus

Information

Microbe Identification

Enhydrobacter aerosaccus

Microbe id: PMDBM2020649
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Enhydrobacter aerosaccus [225324]
Taxonomy Genus: Enhydrobacter [212791]
Taxonomy Family: n.a. [n.a.]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Enhydrobacter aerosaccus

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
Unclassified gene clusterArginineArginine to putrescinePMID: 30183487
Unclassified gene clustern.a.Fatty acids-unassignedPMID: 36782070
Unclassified gene clusterAmino acidsTPP AA metabolismPMID: 36782070
Unclassified gene clusterN.a. / n.a.OD lactate related,OD fatty acidsPMID: 36782070 / PMID: 36782070
Unclassified gene clustern.a.Fatty acids-unassignedPMID: 36782070
Unclassified gene clustern.a.TPP fatty acidsPMID: 36782070
Unclassified gene clusterAmino acidsTPP AA metabolismPMID: 36782070
Unclassified gene clusterN.a. / n.a.TPP fatty acids,OD fatty acidsPMID: 36782070 / PMID: 36782070
Unclassified gene clustern.a.Carnitine degradaion caiTABCDEPMID: 36782070
Ethanolamine degradation S. typhimuriumn.a.Fatty acids-unassignedPMID: 36782070
Bai operon C. scindens ATCCFumarateFumarate to succinatePMID: 28049145
Leucine reductive branch C. sporogenesn.a.Fatty acids-unassignedPMID: 36782070
Acetate to butyrate C. sporogenesn.a.Fatty acids-unassignedPMID: 36782070
Acetate to butyrate C. sporogenesAcetateAcetate to butyratePMID: 17241242
NADH dehydrogenase I E. coliEnergy-capturing-relatedNADH dehydrogenase IPMID: 26443736
Glycine cleavage C. sticklandiiGlycineGlycine cleavagePMID: 8375392
Fumarate2succinate suc dh E. coliFumarateFumarate to succinatePMID: 28049145
Formate dehydrogenase E. coliEnergy-capturing-relatedFormate dehydrogenasePMID: 26443736

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Enhydrobacter aerosaccus


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Unclassified gene clustern.a.HserlactonePMID: 34019648
Unclassified gene clustern.a.RiPP-likePMID: 34019648
Unclassified gene clustern.a.T1PKSPMID: 34019648
Unclassified gene clustern.a.RiPP-likePMID: 34019648
Unclassified gene clustern.a.HserlactonePMID: 34019648
Unclassified gene clustern.a.PhosphonatePMID: 34019648
Unclassified gene clustern.a.Lassopeptide,RRE-containingPMID: 34019648
Unclassified gene clustern.a.RiPP-likePMID: 34019648
Unclassified gene clustern.a.RiPP-like,betalactonePMID: 34019648
Pyxidicycline A / pyxidicycline BPyxidicycline A / pyxidicycline BNRPS-likePMID: 29910943
Malleobactin A / malleobactin B / malleobactin C / malleobactin DMalleobactin A / malleobactin B / malleobactin C / malleobactin DTerpene,redox-cofactorPMID: 23821334, 24707815, 16452439

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Enhydrobacter aerosaccus distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Enhydrobacter aerosaccus in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Enhydrobacter aerosaccus

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Non-alcoholic Fatty Liver Disease PRJNA851946🔗2.9389108832291416S
Crohn Disease PRJNA1156939🔗3.0978444882518516S
HIV Infections PRJNA518910🔗-2.6120188382020716S
Renal Insufficiency, Chronic PRJEB34855🔗2.448926557969216S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Enhydrobacter aerosaccus



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Enhydrobacter aerosaccus



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)